Metraipolis › archive › dc_c947e53296ff
Using advanced cell models for targeted radionuclide therapy evaluation: increased efficacy in 3D versus 2D — Europe PMC PMID:41931239
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41931239
- DOI
- 10.1186/s13550-[numero omesso]-0
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-03T09:25:07.879Z
- SHA-256 of the archived text
f4178c67303641898c9bb0a3efda4a0f9fcec89a35fada86203d6776cc009075- Stable URL of this page
https://metraipolis.com/documento/dc_c947e53296ff
How to cite
Using advanced cell models for targeted radionuclide therapy evaluation: increased efficacy in 3D versus 2D — Europe PMC PMID:41931239 — Europe PMC (en), https://europepmc.org/article/MED/41931239 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c947e53296ff (Metraipolis archive dc_c947e53296ff, sha256 f4178c67303641898c9bb0a3efda4a0f9fcec89a35fada86203d6776cc009075)
BibTeX
@misc{dcc947e53296ff,
title = {Using advanced cell models for targeted radionuclide therapy evaluation: increased efficacy in 3D versus 2D — Europe PMC PMID:41931239},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41931239},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c947e53296ff; sha256 f4178c67303641898c9bb0a3efda4a0f9fcec89a35fada86203d6776cc009075},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41931239. Agents can read the archived copy with the MCP tool read_document.